Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to understand whether it is possible to predict the effectiveness of maintenance treatment with PARP inhibitors following first-line chemotherapy in ovarian cancer, and thus better target the patients who benefit from this treatment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| predictive and prognostic value of the KELIM score | To evaluate the predictive and prognostic value of the KELIM score in patients receiving maintenance treatment with a PARP inhibitor as part of the PAOLA-1 clinical trial. | 18 months |
Not provided
Not provided
Inclusion Criteria: Patients randomised in the PAOLA-1 study -
Exclusion Criteria:Opposition to the use of your data for research purposes.
-
Not provided
Not provided
Not provided
Patients randomised in the PAOLA-1 study :
Patients with advanced FIGO stage IIIB-IV high grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer treated with standard first line treatment combining platinum based chemotherapy plus bevacizumab followed by a maintenance treatment by bevacizumab and Olaparib or placebo.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| ICO Paul Papin | Angers | 49055 | France | |||
| Sainte-Catherine Institut du Cancer Avignon-Provence |
Not provided
Not provided
Not provided
Not provided
| Avignon |
| 84918 |
| France |
| CHRU Besançon - Hôpital Jean Minjoz | Besançon | 25030 | France |
| Polyclinique Bordeaux Nord | Bordeaux | 33300 | France |
| Centre François Baclesse | Caen | 14076 | France |
| Centre Jean Perrin | Clermont-Ferrand | 63011 | France |
| CHU Grenoble-Alpes - Site Nord (La Tronche) | Grenoble | 38043 | France |
| Centre Hospitalier Départemental de Vendée | La Roche-sur-Yon | 85925 | France |
| Centre Azuréen de Cancérologie | Mougins | 06250 | France |
| Hôpital Privé du Confluent | Nantes | France |
| Groupe Hospitalier Diaconesses - Croix Saint-Simon | Paris | 75012 | France |
| Hôpital Cochin | Paris | 75014 | France |
| Hôpital Européen Georges Pompidou | Paris | 75015 | France |
| Institut Curie | Paris | 75248 | France |
| Clinique Francheville | Périgueux | 24004 | France |
| HCL - Centre Hospitalier Lyon Sud | Pierre-Bénite | 69495 | France |
| CHU de Poitiers - Hôpital de la Milétrie | Poitiers | 86021 | France |
| Centre Eugène Marquis | Rennes | 35042 | France |
| ICO - Centre René Gauducheau | Saint-Herblain | 44805 | France |
| Oncopole Claudius Regaud - IUCT Oncopole | Toulouse | 31059 | France |
| Clinique Pasteur | Toulouse | 31300 | France |
| ICL - Centre Alexis Vautrin | Vandœuvre-lès-Nancy | 54519 | France |
| Gustave Roussy | Villejuif | 94805 | France |
| Centre Hospitalier Princesse Grace | Monaco | 98012 | Monaco |
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 | Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |
Not provided
Not provided